Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - REVENUE
Revenue URGN - UroGen Pharma Ltd.
82.7 M
LAST VALUE
31.21%
2 YEAR CAGR
136.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR